In this sense gene therapy is "disruptive innovation" in the Clayton M Christensen sense of the word: the incumbents cannot pursue the strategy as doing so eats into their profits. Does it take smaller, independent, outfits to pursue this?
The problem is if searching for one-shots gets to be unprofitable altogether.